In another gene expression analysis, NCKAP1L was found to be significantly overexpressed in B-cell chronic lymphocytic leukemia (CLL) cells expressing high CD38, a cell marker associated with poor clinical outcome. The gene discussed is NCKAP1L; the disease is B-cell chronic lymphocytic leukemia.